Overseas Expansion And InsurTech Collaborations Will Unlock Future Diversification

Published
23 Feb 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
₩3,337.50
6.4% undervalued intrinsic discount
14 Aug
₩3,125.00
Loading
1Y
7.0%
7D
-8.0%

Author's Valuation

₩3.3k

6.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 5.55%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Increased 0.74%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 1.48%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 6.05%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.80%

Shared on26 Mar 25
Fair value Decreased 4.57%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 2.80%

AnalystConsensusTarget has increased revenue growth from -58.5% to -41.5%, decreased profit margin from 50.4% to 18.6%, increased future PE multiple from 3.3x to 4.1x and increased shares outstanding growth rate from -0.1% to 0.0%.

Shared on12 Mar 25
Fair value Decreased 1.04%

AnalystConsensusTarget has decreased revenue growth from -41.3% to -58.5%, increased profit margin from 17.3% to 50.4% and decreased future PE multiple from 4.3x to 3.3x.